Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy. - Wikidata - wikimedia - TriplyDB

Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy.

Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy.

http://www.wikidata.org/entity/Q37049808

about

The metabolic syndrome and renal function in an African cohort infected with human immunodeficiency virus

P2860

Q57821981-327FC207-1160-400E-93B1-3B3467C61D6F

P2860

Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy.

http://www.wikidata.org/entity/Q37049808

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Urinary albumin-to-creatinine ...... eiving antiretroviral therapy.

@en

Urinary albumin-to-creatinine ...... eiving antiretroviral therapy.

@nl

type

label

Urinary albumin-to-creatinine ...... eiving antiretroviral therapy.

@en

Urinary albumin-to-creatinine ...... eiving antiretroviral therapy.

@nl

prefLabel

Urinary albumin-to-creatinine ...... eiving antiretroviral therapy.

@en

Urinary albumin-to-creatinine ...... eiving antiretroviral therapy.

@nl

P1433

Q37049808-56949683-E540-470D-A02D-58A9C5E8F1C5

P1476

Q37049808-9E58D5F6-6A75-43F9-A3E6-B7A21327D15A

P2093

Q37049808-11B1BE17-7EA0-4079-B6E7-226AD7C5F711

Q37049808-5B2C82E7-F689-47E4-8C7E-180503E77DE7

Q37049808-826C64AD-078C-4E90-8538-4D8AAFAB90DA

Q37049808-97828178-EC36-469C-8697-0C954224670E

Q37049808-D01A7AC0-79AA-48F3-94BA-856F6C0154D1

Q37049808-D3C91F3A-3AA9-4FE4-9258-CD0141C0F178

Q37049808-DED221C4-B6DF-4733-AF03-614492311FF9

Q37049808-FF4E193B-4A8D-4287-9E03-670AE2145FA8

P2860

Q37049808-110B5125-40B9-42C8-9E14-4390315E627D

Q37049808-194B76A0-2B73-4D38-B807-F0A506EFC1F6

Q37049808-20732F17-46AA-4679-BF51-E8E62686973A

Q37049808-21BA4522-2FD2-41E9-8429-66D263F9DC3C

Q37049808-228C5BC8-831E-42FC-BE8F-F56CFA46B2C2

Q37049808-23E6B972-0E84-4DD5-A930-218A52D94DD5

Q37049808-266F856F-5D69-43E2-9E14-B578AC7665C0

Q37049808-2855E1E5-D3DA-41A8-AA18-634CC7113600

Q37049808-286BFCFE-5B29-4EB4-9D96-D36A4FF01BE9

Q37049808-29CC23BF-965C-41C4-9409-962C265A7CC9

P2888

Q37049808-51CCBAB9-75AA-426C-A372-620B9E3B73E6

P304

Q37049808-2022D9A5-C037-44A6-9B76-B28F0596F825

P31

Q37049808-FFC9052D-CA5F-48D5-AF97-E86A4772B42A

P356

Q37049808-24974599-5208-49BC-81FB-7670B477DADC

P407

Q37049808-0E8DB9A0-B1AD-4418-959B-A402FBD0F15D

P478

Q37049808-0E950584-BEA2-4DAF-B006-5BB429CA1D13

P50

Q37049808-94A9C9B3-9197-4C83-9354-B51E3BA79235

P577

Q37049808-3D49CF63-B2C2-4E89-9B5C-0EE68DB38C15

P6179

Q37049808-EDF83F21-DBCF-4B29-BBB6-FBDDBDF1254C

P698

Q37049808-9C04AA89-15A5-4079-8394-860B250B3D00

P921

Q37049808-3C251DFE-34D5-4025-AB7A-44B2904BD74A

Q37049808-C5F50939-0B0E-4ADB-86F7-60A92C9DF742

P932

Q37049808-E5730CD4-F282-4320-B5C8-907CC830A589

P356

P1433

Scientific Reports

P1476

Urinary albumin-to-creatinine ...... eiving antiretroviral therapy.

@en

P2093

Daniela Francisci

http://www.w3.org/2001/XMLSchema#string

Elisabetta Schiaroli

http://www.w3.org/2001/XMLSchema#string

Elmo Mannarino

http://www.w3.org/2001/XMLSchema#string

Francesco Bagaglia

http://www.w3.org/2001/XMLSchema#string

Franco Baldelli

http://www.w3.org/2001/XMLSchema#string

Massimo R Mannarino

http://www.w3.org/2001/XMLSchema#string

Matteo Pirro

http://www.w3.org/2001/XMLSchema#string

Vanessa Bianconi

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.

Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.

Microalbuminuria predicts overt proteinuria among patients with HIV infection

Microalbuminuria, endothelial dysfunction and cardiovascular risk.

Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study.

Is the presence of microalbuminuria a relevant marker of kidney disease?

Albuminuria is associated with elevated acute phase reactants and proinflammatory markers in HIV-infected patients receiving suppressive combination antiretroviral therapy.

Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review

Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.

P2888

P304

28741

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP28741

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Amirhossein Sahebkar

P577

2016-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1007284290

http://www.w3.org/2001/XMLSchema#string

P698

27353425

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4926110

http://www.w3.org/2001/XMLSchema#string